<SOS> [ Improving wound healing after nose surgery by combined administration of xylometazoline and dexpanthenol ] . BACKGROUND The aim of this study was the examination of efficacy and tolerability of an application-form of the new combination of Xylometazoline with Dexpanthenol ( Nasic ) versus Xylometazoline alone . PATIENTS AND METHODS Randomized verum controlled parallel-group-comparison of two weeks treatment of a nasal-spray . 61 inpatients with the diagnosis Rhinitis following nasal operation were included in this study and 30 patients were treated with verum and placebo each . The assessment of nasal-breathing-resistance according to scores was defined as target-parameter . Confirmatory statistical analysis was carried out according to Wilcoxon-Mann-Whitney-U two-sided at alpha < or = 0.05 . MAIN OUTCOME MEASURE The superiority of the combination of Xylometazoline-Dexpanthenol nasal-spray versus Xylometazoline nasal spray could be proven for the target-parameter as clinically relevant and statistically significant . The clinically proven efficacy is emphasized by good tolerability of both treatments . Due to easy handling of the nasal-spray a good compliance was confirmed . CONCLUSION Distinct improvement of symptoms in patients following nasal operations underlines the efficacy of both medications . With respect to the tolerability therapy with the combination is more beneficial in comparison to the alternative therapy . The result of this controlled clinical study confirms that the combination Xylometazoline-Dexpanthenol is an enlargement and improvement of effective medicinal treatment of rhinitis following nasal operation in comparison to therapy with Xylometazoline alone . <EOS>